This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

Browse

Tetramethoxyluteolin

Methylated luteolin analog ("luteoluxa") engineered for vastly better oral absorption and brain penetration than the parent flavonoid.

Aliases (8)
3 · 4 · 5 · 7-tetramethoxyluteolin · methoxy-luteolin · luteoluxa · tetramethyl-luteolin · TML
TYPICAL DOSE
50-100 mg of tetramethoxyluteolin per capsule, …
Daily
ROUTE
CYCLE
STORAGE

Overview

What is Tetramethoxyluteolin?

Tetramethoxyluteolin (methylated luteolin) is a synthetic methoxylated derivative of the natural flavonoid luteolin, designed for improved bioavailability and metabolic stability. It is researched as a mast cell stabilizer and anti-neuroinflammatory agent, popularized by Theoharides for use in mast cell activation syndrome and related conditions.

Key Benefits

Stabilizes mast cells and reduces histamine/cytokine release, attenuates neuroinflammation (investigated for autism, brain fog, mast cell activation syndrome), and shows antioxidant and neuroprotective effects.

Mechanism of Action

Methoxyluteolin inhibits mast cell degranulation by blocking calcium-dependent and IgE-mediated release pathways, modulates microglial activation, and inhibits NF-κB inflammatory signaling. Methoxylation enhances oral absorption and CNS penetration vs unmodified luteolin.

Research Indications

Most Effective

Retains and amplifies mast-cell stabilizing activity

in head-to-head in-vitro comparisons against parent luteolin, the methylated analog is reportedly 10-100× more potent at suppressing IL-6…

Peptide Interactions

luteolin (parent):
Synergistic

Same family; some products combine for "spectrum" effect

quercetin:
Synergistic

Another mast-cell stabilizer with different binding profile; common combo in NeuroProtek

palmitoylethanolamide (PEA-Ultra):
Synergistic

Different mechanism (PPAR-α, endocannabinoid system) but parallel anti-neuroinflammatory effect

apigenin:
Synergistic

Both flavonoids, both anti-inflammatory; logical co-administration

What to Expect

  • Week 1
    Tolerability and dose-response.
  • Week 2-4
    Early effect window.
  • Week 4-8
    Peak benefit assessment.
  • Week 8+
    Cycle decision point.

Side Effects & Safety

  • Common (>10% users): None at typical doses; very clean safety profile
  • Less common (1-10%): Mild GI upset, occasional mild headache during initial weeks
  • Rare-serious (<1%): None reported in available literature
  • Theoretical: Antiplatelet effect of flavonoids in general — caution if on warfarin or other anticoagulants
  • Specific watch periods: None established
Was this helpful?
Your feedback shapes what we research deeper.

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load
Loading…
Continue: Extended research →
Our verdict, decision matrix, deep dives, controversies, sources